Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/includes/bootstrap.inc).

New Company Submissions (Unconfirmed)

Signal Bay Inc.
SGBY
11/24/2014
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10328122
Consulting Services
Signal Bay is committed to bringing compliance and testing services to the emerging cannabis industry. Our scientists are dedicated to ensuring the highest standards of product safety and quality. Business and Licensing Services:
Signal Bay brings the best talent to emerging industries. Our experienced consultants provide advice and support on issues ranging from startup and investment planning, to license acquisition and business operations.
Submitted: 08/10/2015 - 3:21pm
Mgmmdamarijuannaltd
MMG
07/04/2015
  • Acquisitions
  • Cannabinoid Profiling
  • Cannabis And Hemp
  • -Cannabis
  • -Medical Marijuana
  • -Pharmaceuticals
  • --Natural Pharmaceuticals
  • --Synthetic Cannabinoids
Our main gold is to give our customers the best the need we make them proud of us...
Submitted: 07/02/2015 - 4:21pm
Twilightgroups co.,ltd
0908908
05/12/2015
www.twilightgroups.org
Advisory Boards
Submitted: 05/12/2015 - 9:47pm
MOTIF INVESTING
THE 420 FUND
-Recreational Cannabis
This is the worlds first cannabis themed fund. We have chosen companies we feel will prosper when we have a uniformed national cannabis law.
Submitted: 02/07/2015 - 4:00pm
Quasar Aerospace Industries, Inc.
QASP
03/24/2014
accesswire, twitter - quasarcannabis
  • Acquisitions
  • Brand Development
  • -Cultivation
  • -Retail Sales
  • Cash Transport
  • CBD Extracts
  • Consulting Services
  • Equipment Leases
  • Gowing Facilities
  • Grow Equipment
  • Legal Compliance
  • Online Store
  • -Cannabis
  • Pot Stocks
  • Products
  • THC Extracts
  • Websites
  • Growing Equipment
  • -Fertilizers
  • -Intelligent Grow Systems
  • -Self-Contained Growing Systems
  • -Lights
  • -Soil
  • -Grow Facilities
  • -Power Systems
  • -Business Guidance
  • -Legal Compliance And Protection
  • -Clothing
  • -Grow Facility Leases
  • -Facility Security
  • -Growers
  • -Medical Marijuana
  • -Recreational Cannabis
  • -Extracts
  • --CBD
  • --THC
Quasar Aerospace Industries, Inc. (QAI) is an integrated aviation/aerospace and legal and medical marijuana service provider corporation which has been created to pursue an innovative and highly synergistic business strategy to train aircraft pilots and develop a unique and competitive marijuana corporation. This strategy will be achieved through a process by which several businesses in the aviation/aerospace and marijuana industry will be combined into an integrated and self-supporting network which will have the ability to operate in a more complex strategic environment and to achieve greater success than would have been possible if they were operating purely alone. Within this context QAI will acquire and operate these business units according to the master corporate plan. Aerospace/aviation industry and the marijuana service provider corporation will retain their operational independence and unique corporate cultures separate from each other while operating under QAI.
Submitted: 02/05/2015 - 3:55pm
cbis
Submitted: 01/04/2015 - 12:49pm
CannaSys, Inc.
MJTK
12/12/2014
http://finance.yahoo.com/news/cannasys-inc-announces-stock-ticker-130000443.html
Software
CannaSys creates, develops and commercializes innovative technology to solve problems, create opportunities and streamline the connections between producer, seller, and consumer patient segments in the cannabis industry. To date, CannaSys has developed four distinct brands and is working toward industry adoption and monetizing of its current offerings, CannaCash, CannaTrade, ExchangeHemp and CannAssist. CannaCash is an affiliate-based membership rewards loyalty program. CannaTrade is a market-style wholesale cannabis matching service, initially being released in the state of Colorado. ExchangeHemp is a hemp marketplace based on the CannaTrade platform. CannAssist is a technology installation, service and support team serving the Cannabis industry.
Submitted: 12/08/2014 - 10:34am
ReelTime Rentals, Inc.
RLTR
http://globenewswire.com/news-release/2014/11/25/686081/10109846/en/ReelTime-Lands-CannaBrands-as-Title-Sponsor-for-LoudMouth-News.html?ev=1
  • Advertising
  • Media
James Hodge, Chairman and CEO of ReelTime remarked, "Today's agreement with CannaBrands marks the beginning of a relationship that will be mutually beneficial to both parties. LoudMouth News serves as a news portal for the controversial emerging cannabis industry via a rapidly expanding main stream media network. CannaBrands is well situated as the leading Cannabis branding company to provide continuing support for LoudMouth News. The revenue from this sponsorship alone solidifies the demand and desire for emerging companies to invest in our program. We have now realized significant revenue for the last quarter of 2014 and throughout 2015." "This effort is part of a national media strategy that is being executed by ReelTime and Canna Brands that we expect to continue and expand over time. This is only the beginning." LoudMouth News, the first in a series of business news based productions being created by ReelTime Media Group, is an effort to spread awareness of publically traded companies and products that are shaping the emerging marijuana industry. LoudMouth news serves to provide news coverage on the expansion of this emerging sector and the company's active in the marketplace. LoudMouth News, the first in a series of business news based productions being created by ReelTime Media Group, is an effort to spread awareness of publically traded companies that are shaping the emerging legal marijuana industry. ReelTime Media Group is in the business of identifying and monetizing individuals and companies who have been thrust into the public eye through the media. This awareness may come as a result of being featured on a TV show, news worthy event, or viral social media exposure. Most individuals and companies are not prepared to monetize such exposure and often times find the exposure passes without having used it to their advantage. ReelTime through its partners is uniquely positioned to capitalize on the exposure and to maximize the benefits. Maximizing the opportunity may be achieved via merchandising, leveraging exposure into relationships, creating and marketing new revenue streams for existing products, and launching new products. ReelTime also helps increase the exposure that its partners receive and aid in the shaping of its image.
Submitted: 12/06/2014 - 8:44am
CannaBrands, Inc
CBMJ
http://www.mlive.com/prnewswire/prntravel.ssf?/mlive/story/?catSetID=&catID=&nrid=277564691&page=147
Canna Brands acquires, develops and markets branded cannabis specialty goods for infusion and distribution by licensed processors in the states of Colorado and Washington where the recreational consumption of cannabis infused products, such as bottled sodas, coffee beverages, baked goods and others, is now legal for persons 21 years or over. On September 25, 2014, Canna Brands announced the signing of its first operational agreement with Nana's Secret Soda – the premier cannabis infused soda brand in the State of Washington. About Canna Brands, Inc.
Submitted: 12/06/2014 - 8:38am
Sigma-Aldrich Corporation
SIAL
12/02/2014
http://www.prnewswire.com/news-releases/cerilliant-introduces-snap-n-spike--snap-n-shoot-certified-reference-materials-for-cannabis-testing-applications-300002747.html
Testing
Cerilliant Introduces Snap-N-Spike® ? Snap-N-Shoot® Certified Reference Materials for Cannabis Testing Applications The Cerilliant® brand within its Applied Diagnostics and Testing business segment has introduced new solution-based Certified Reference Materials (CRMs) of seven Cannabis biomarkers – cannabidivarin (CBDV), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabichromene (CBC), cannabidiolic acid (CBDA), delta9-tetrahydrocannabinolic acid A (THCA-A), and tetrahydrocannabivarin (THCV). These cannabinoid CRMs are suitable for use in Cannabis testing applications by GC, GC/MS, HPLC, or LC-MS/MS, including potency testing, cannabinoid and impurity profiling, pharmaceutical research, or forensic analysis. Cerilliant provides these and other certified solution standards of cannabinoids in a U.S. DEA and Health Canada (with TK #'s) exempt solution format, allowing laboratories to place orders without additional regulatory paperwork. Cerilliant's cannabinoid solution CRMs are manufactured and certified to the highest industry standards including ISO Guide 34, ISO/IEC 17025, and ISO 13485. Each certified reference standard produced by Cerilliant includes a comprehensive Certificate of Analysis (COA) containing uncertainty and traceability information in accordance with ISO guidelines and for satisfaction of laboratory regulatory requirements. Cerilliant Corporation is a subsidiary of Sigma-Aldrich. Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 200,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 37 countries, has more than 9,000 employees worldwide, and had sales of $2.7 billion in 2013.
Submitted: 12/06/2014 - 8:31am
NEMUS Bioscience, Inc.
NMUS
http://globenewswire.com/news-release/2014/12/04/688806/10111081/en/NEMUS-to-Move-Forward-With-Cannabinoid-Based-Therapy-for-Open-Angle-Glaucoma.html?ev=1
-Pharmaceuticals
Biopharmaceutical company, headquartered in Costa Mesa, California, focused on the discovery, development, and commercialization of cannabis-based therapeutics for global markets with significant unmet medical needs. Utilizing certain proprietary technology licensed from the University of Mississippi, NEMUS is working to develop novel ways to deliver cannabis-based drugs for specific indications, with the aim of optimizing the clinical effects of such drugs, while limiting the potential adverse events. NEMUS's strategy is not limited to the sole use of either natural or synthetic inputs. NEMUS to Move Forward With Cannabinoid-Based Therapy for Open-Angle Glaucoma "These in vivo studies using an animal model of glaucoma were the pivotal first steps in developing our proprietary THC pro-drug as a potential therapeutic option for the management of glaucoma," stated NEMUS Bioscience CEO, John Hollister. "The glaucoma market is in need of newer, more efficacious agents to combat this progressive, debilitating disease and NEMUS is dedicated, through our relationship with the University of Mississippi, to bringing innovative compounds forward in the eye-care market." NEMUS CMO, Dr. Brian Murphy. "Our collaboration with the University, a pioneer in the science of cannabis-derived medicinals, has yielded THC formulation options that achieve significant drug concentration into all chambers of the eye in animal testing, broadening the potential ophthalmic indications beyond glaucoma for this drug, and other cannabinoid-based compounds currently in development." Professor Mahmoud ElSohly of the National Center for Natural Products Research at the University of Mississippi, reports that further work is dedicated to bringing a variety of cannabis-derived compounds to their therapeutic potential. "Cannabinoid receptors are located in organ systems throughout the body, exerting a variety of physiological activities. Our team is working to construct novel extraction, purification, and formulation methods to deliver these molecules to patients, especially those suffering from conditions of unmet medical needs." NEMUS Bioscience and the University of Mississippi entered into a research and in-licensing collaboration agreement this year.
Submitted: 12/06/2014 - 7:19am
SunOpta Inc.
STKL
http://globenewswire.com/news-release/2014/12/04/688651/10110960/en/SunOpta-Announces-Expansion-of-Aseptic-Processing-and-Filling-Operations-to-Meet-Increased-Demand.html?ev=1
Beverages
Possible producer of hemp milk

"A leading global company focused on natural and organic foods, today announced a significant expansion project at its Allentown, Pennsylvania facility to meet continued customer demand for aseptically processed healthy beverages." "SunOpta's vertically integrated aseptic beverage capabilities are unique and incorporate raw material sourcing through ingredient production and finished packaged products, providing for control of quality, organic certification, and traceability from the farm to finished packaged product. Current production capabilities include soymilk, rice beverage, almond beverage, hemp milk, sunflower milk, ancient grain beverages, coconut based beverages, nutritional beverages, teas, dairy products and broths among others. "
Submitted: 12/04/2014 - 12:21pm
Gold Coast Mining Corporation
GDSM
Consulting Services
Gold Coast Mining Corp. is an innovative and opportunistic provider of services and products to the high growth legal marijuana industry. The Company targets niches were it can be the leader while concentrating on generating revenues, profits and substantial returns to its shareholders.
Submitted: 11/30/2014 - 2:04pm
Kaneh Bosm BioTechnology Inc.
KBB:CSE
http://www.cnsx.ca/cmsAssets/docs/Filings/2014/2014_11_07_16_33_13_KBB_Kaneh_Bosm_Appoints_New_CFO_and_Corporate_Sales_and_Marketing_Advisor.pdf
Kaneh Bosm BioTechnology Inc. (formerly Anexco Resources Ltd.)

Kaneh Bosm’s ‘Cannabis Dream Team’ has identified a number of high value strategic entry points into this sector. We believe this multiple revenue stream model will maximize shareholder value and catapult Kaneh Bosm into a leadership position within the Cannabis sector.

At Kaneh Bosm our depth of experience within the Cannabis sector gives us a notable advantage understanding this business by predicting market trends and favourably positioning the corporation to earn maximum profits. We identified the strategic verticals that exist within this sector, and we have selected those that strongly support our team’s strengths.
Submitted: 11/12/2014 - 10:34am
Cannagrow Holdings, Inc.
CGRW
https://finance.yahoo.com/news/cannagrow-holdings-inc-cgrw-establishes-130000745.html
Submitted: 11/12/2014 - 9:26am
Everlert, Inc.
EVLI
http://globenewswire.com/news-release/2014/11/11/682023/10107575/en/Everlert-Adds-New-Board-Members-and-Officers-to-Support-the-Launch-of-Expanded-Operations.html?ev=1
Mr. Hymers is currently serving as the CFO of a publicly traded company called Global Hemp Group (OTC:GBHPF). Mark Blankenship, Virgil L. Nickell and Robert L. Hymers III were appointed to Everlert's board of directors. Darin Shaw, as the President and Chairmen of the Board, made the appointments to strengthen the Company's management capabilities. Robert Hymers was the president and CEO of Everlert until he resigned in July of 2014.
Submitted: 11/12/2014 - 9:22am
Seymour Wellness Society
-
01/01/2014
http://seymourwellnesssociety.com
-Medical Marijuana
As a premier Vancouver Dispensary for medicinal cannabis, Seymour Wellness Society is a non profit organization dedicated to assisting patients to get access to medicinal marijuana. We offer a newly renovated vape lounge and fully stocked smoke shop with a variety of product and edibles. The best Vancouver Dispensary for Medicinal Cannabis treatments.
Submitted: 11/12/2014 - 2:00am
ViaDerma, Inc.
VDRM
http://www.viadermalicensing.com/landing2.html#tab3
A specialty pharmaceutical company committed to bringing new products to market through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to wound care. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action. Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis.
Applications: "Medical Cannabis - Medical cannabis (or medical marijuana) refers to the use of cannabis and its constituent cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), as medical therapy to treat disease or alleviate symptoms. Cannabis has been used to reduce nausea and vomiting in chemotherapy and people with AIDS, and to treat pain and muscle spasticity. Medical cannabis can be administered using a variety of methods, including vaporizing or smoking dried buds, eating extracts, and taking capsules. ViaDerma is developing a topical form of medical cannabis that can be sprayed or rubbed into the skin. In the United States the medical marijuana industry is a $1.43B business"
Submitted: 10/31/2014 - 1:59pm
AXIM Biotechnologies
AXIM
10/30/2014
http://globenewswire.com/news-release/2014/10/30/678205/10105385/en/AXIM-Biotechnologies-Delivers-Net-Negative-Carbon-Footprint-With-All-Natural-Industrial-Hemp.html?ev=1
-Hemp
Strategic focus: bring to market global innovative solutions that set the "green standard" in the industrial hemp industry. AXIM Biotechnologies' business model harnesses the power of industrial hemp to benefit human health, provide alternative energy and deliver many other innovative applications. The Company develops strategic partnerships and acquisitions, allowing ongoing research and development in functional foods, nutraceuticals, pharmaceuticals, cosmetics, and clean energy. "The primary agenda is to provide nutrition, fabric, sustainable alternative energy, pharmaceutical and nutraceutical products. All of these will be produced utilizing innovative, proprietary and environmentally cautious technologies." AXIM Biotechnologies is focused upon unique proprietary delivery mechanisms for the introduction of cannabinoids (i.e. CBD, CBG, CBN), finding solutions for conditions for which there is currently no effective treatment. AXIM Biotechnologies (OTC:AXIM) is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy.
Submitted: 10/30/2014 - 4:50pm
Weed Growth Fund, Inc.
OVRI
https://www.sec.gov/Archives/edgar/data/1580297/000147793214005547/ovri_ex101.htm
-Investment Firms
"Last month (Sep 2014), the company changed its name to Weed Growth Fund through the Nevada Secretary of State. Until recently, Ovation Research Inc. operated as a subsidiary of the New Compedium Corporation."

http://www.nasdaq.com/markets/ipos/company/ovation-research-inc-909980-72936
Submitted: 10/27/2014 - 10:41am